Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7

被引:32
|
作者
Renneboog, B
Hansen, V
Heimann, P
DeMulder, A
Janssen, F
Ferster, A
机构
[1] HOP UNIV ENFANTS REINE FABIOLA,HAEMATOONCOL UNIV,B-1020 BRUSSELS,BELGIUM
[2] HOP UNIV ENFANTS REINE FABIOLA,NEPHROL UNIT,B-1020 BRUSSELS,BELGIUM
[3] HOP BRUGMANN,LAB HAEMATOL & CYTOGENET,BRUSSELS,BELGIUM
关键词
t-MDS; myelodysplasia; monosomy; 7; azathioprine;
D O I
10.1046/j.1365-2141.1996.00400.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe a case of spontaneously reversible refractory anaemia, a subtype of myelodysplastic syndrome (MDS), with monosomy 7 secondary to chronic treatment with azathioprine (AZA) in a young renal transplant recipient, AZA was stopped after that conventional cytogenetics and fluorescence in situ hybridization (FISH) had demonstrated the existence of a monosomy 7 clone. 4 months later, haematological values had considerably improved and the karyotypic examination as well as the FISH analysis were normal. The spontaneous remission of this MDS with monosomy 7, which is usually associated with a particularly poor prognosis, could be due to the recovery of a better immunosurveillance following the withdrawal of AZA.
引用
收藏
页码:696 / 698
页数:3
相关论文
共 50 条
  • [31] Therapy-Related Myelodysplastic Syndrome (MDS) Lacking High-Risk Karyotype Resembles De Novo Disease and Differs from Conventional Therapy-Related MDS
    Hasserjian, R. P.
    Chi, Y. Ok
    Hu, Y.
    Kluk, M.
    Attar, E.
    Wang, S. A.
    LABORATORY INVESTIGATION, 2011, 91 : 300A - 300A
  • [32] Therapy-Related Myelodysplastic Syndrome (MDS) Lacking High-Risk Karyotype Resembles De Novo Disease and Differs from Conventional Therapy-Related MDS
    Hasserjian, R. P.
    Chi, Y. Ok
    Hu, Y.
    Kluk, M.
    Attar, E.
    Wang, S. A.
    MODERN PATHOLOGY, 2011, 24 : 300A - 300A
  • [33] Identification Of Genes/Signaling Pathways That Predispose To Therapy Related MDS (t-MDS)
    Akunuru, Shailaja
    Seymore, Kimberly
    Nattamai, Kalpana
    Zheng, Yi
    Geiger, Hartmut
    BLOOD, 2013, 122 (21)
  • [34] Outcomes of patients with therapy-related AML/myelodysplastic syndrome (t-AML/MDS) following hematopoietic cell transplantation
    Alam, N.
    Atenafu, E. G.
    Kuruvilla, J.
    Uhm, J.
    Lipton, J. H.
    Messner, H. A.
    Kim, D. H.
    Seftel, M.
    Gupta, V.
    BONE MARROW TRANSPLANTATION, 2015, 50 (09) : 1180 - 1186
  • [35] Outcomes of patients with therapy-related AML/myelodysplastic syndrome (t-AML/MDS) following hematopoietic cell transplantation
    N Alam
    E G Atenafu
    J Kuruvilla
    J Uhm
    J H Lipton
    H A Messner
    D H Kim
    M Seftel
    V Gupta
    Bone Marrow Transplantation, 2015, 50 : 1180 - 1186
  • [36] Therapy-related myelodysplastic syndrome in adults with neurofibromatosis
    Papageorgio, C
    Seiter, K
    Feldman, EJ
    LEUKEMIA & LYMPHOMA, 1999, 32 (5-6) : 605 - 608
  • [37] Therapy-related myelodysplastic syndrome: a case study
    Manabe, Masahiro
    Wada, Katsuya
    Momose, Dai
    Sugano, Yasuyoshi
    Hino, Masayuki
    Yamane, Takahisa
    Ishida, Eiwa
    Koh, Ki-Ryang
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2015, 5 (02): : 91 - 94
  • [38] A Prognostic Model of Therapy-Related Myelodysplastic syndrome
    Kim, Hawk
    Jabbour, Elias
    Kadia, Tapan
    Borthakur, Gautam
    Pierce, Sherry
    Shan, Jianqin
    Cortes, Jorge
    Ravandi, Farhad
    Wierda, William G.
    Estrov, Zeev
    Faderl, Stefan
    Garcia-Manero, Guillermo
    BLOOD, 2009, 114 (22) : 1460 - 1460
  • [39] TREATMENT OF THERAPY-RELATED LEUKEMIA AND MYELODYSPLASTIC SYNDROME
    KANTARJIAN, HM
    ESTEY, EH
    KEATING, MJ
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1993, 7 (01) : 81 - 107
  • [40] Therapy-Related Myelodysplastic Syndrome: Models and Genetics
    Graubert, Timothy
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (01) : S45 - S47